Inhibition of the AKT/mTOR and erbB pathways by gefitinib, perifosine and analogs of gonadotropin-releasing hormone I and II to overcome tamoxifen resistance in breast cancer cellsMartin L. Block, Andreas R. Günthert|International Journal of Oncology|2012Cited by 35